映恩生物-B(09606)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09606 映恩生物-B

未开盘 12-22 16:08:10

330.400

-6.200

-1.84%

最高337.600	最低326.600	成交量45.21万
今开336.600	昨收336.600	日振幅3.27%
总市值293.66亿	流通市值293.66亿	总股本8,888万
成交额1.50亿	换手率0.51%	流通股本8,888万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09606","market":"HK","secType":"STK","nameCN":"映恩生物-B","latestPrice":330.4,"timestamp":1766390890007,"preClose":336.6,"halted":0,"volume":452101,"delay":0,"floatShares":88879200,"shares":88879200,"eps":-145.26240874020706,"marketStatus":"未开盘","change":-6.2,"latestTime":"12-22 16:08:10","open":336.6,"high":337.6,"low":326.6,"amount":149501110,"amplitude":0.03268,"askPrice":330.6,"askSize":19800,"bidPrice":330.4,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-126.01774028162316,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766453400000},"marketStatusCode":0,"adr":0,"listingDate":1744646400000,"exchange":"SEHK","adjPreClose":336.6,"openAndCloseTimeList":[[1766367000000,1766376000000],[1766379600000,1766390400000]],"volumeRatio":0.5106659018470304,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09606","defaultTab":"news","newsList":[{"id":"2592579031","title":"每日卖空追踪 | 映恩生物-B 12月19日卖空量成交1.78万股，卖空比例为0.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592579031","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592579031?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:30","pubTimestamp":1766133040,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间12月19日，涨9.29%，卖空量成交1.78万股，较上一交易日减少56.69%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163639a45f385a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163639a45f385a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252160.HKD","HK0000500386.USD","LU2543165471.USD","HK0000252152.HKD","BK1161","09606"],"gpt_icon":0},{"id":"2592415714","title":"映恩生物-B12月19日主力净流入1207.5万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2592415714","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592415714?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:15","pubTimestamp":1766132122,"startTime":"0","endTime":"0","summary":"12月19日, 映恩生物-B股价涨9.29%，报收336.60元，成交金额6.4亿元，换手率2.15%，振幅9.68%，量比3.03。映恩生物-B今日主力资金净流入1207.5万元，上一交易日主力净流出126万元。该股近5个交易日上涨3.19%，主力资金累计净流出683.4万元；近20日主力资金累计净流入3016.9万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219161633a6b62e8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219161633a6b62e8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252160.HKD","HK0000500386.USD","LU2543165471.USD","HK0000252152.HKD","BK1161","09606"],"gpt_icon":0},{"id":"2592364871","title":"港股异动 | 映恩生物-B(09606)早盘涨超3% DB-1310获美国FDA授予快速通道资格","url":"https://stock-news.laohu8.com/highlight/detail?id=2592364871","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592364871?lang=zh_cn&edition=full","pubTime":"2025-12-19 09:42","pubTimestamp":1766108560,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，映恩生物-B早盘涨超3%，截至发稿，涨3.25%，报318港元，成交额2339.55万港元。据悉，DB-1310成为全球首款在此适应症上获FTD的HER3-ADC药物。DB-1310在HR+/HER2-乳腺癌中的FTD适应症范围较广，涵盖“在不可切除或转移性疾病阶段接受或未接受过化疗”的患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383479.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09606","BK1161","HK0000252152.HKD","LU2543165471.USD","HK0000500386.USD","BK4566","BK4118","BK4588","BK4585","HK0000252160.HKD","DB","BK4552"],"gpt_icon":0},{"id":"2592571081","title":"全球首款！映恩生物HER3-ADC治疗HR+/HER2-乳腺癌获FDA授予FTD","url":"https://stock-news.laohu8.com/highlight/detail?id=2592571081","media":"药渡Daily","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592571081?lang=zh_cn&edition=full","pubTime":"2025-12-18 17:20","pubTimestamp":1766049621,"startTime":"0","endTime":"0","summary":"今日，映恩生物在其官网宣布，公司开发的新型HER3ADC药物DB-1310获FDA授予快速通道资格认定，适应症为既往接受过内分泌治疗、CDK4/6抑制剂治疗，且在不可切除或转移性疾病阶段接受或未接受过化疗，或在完成辅助化疗期间或结束后6个月内出现疾病复发的成人晚期/不可切除或转移性激素受体阳性、人表皮生长因子受体2阴性乳腺癌患者。根据映恩生物官网显示，DB-1310是全球首款在此适应症上获FTD的HER3-ADC药物。研究治疗相关停药率低参考文献映恩生物官网","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218174009a45aed31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218174009a45aed31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000500386.USD","09606","HK0000252152.HKD","BK1161","HK0000252160.HKD","LU2543165471.USD"],"gpt_icon":0},{"id":"2592292485","title":"映恩生物-B跌1.90% 股价跌破300港元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2592292485","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592292485?lang=zh_cn&edition=full","pubTime":"2025-12-18 09:31","pubTimestamp":1766021517,"startTime":"0","endTime":"0","summary":"2025年12月18日早盘09时31分，映恩生物-B股票出现波动，股价急速下跌1.90%。截至发稿，该股报299.600港元/股，成交量7800股，换手率0.01%，振幅2.69%。映恩生物-B股票所在的生物技术行业中，整体涨幅为1.43%。其相关个股中，派格生物医药-B、基石药业-B、百济神州涨幅较大，振幅较大的相关个股有圣诺医药-B、拨康视云-B、歌礼制药-B，振幅分别为4.96%、4.08%、3.81%。映恩生物-B公司简介：映恩生物是一家主要从事临床阶段生物制药的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218093157a6b020f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218093157a6b020f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252152.HKD","09606","LU2543165471.USD","BK1161","HK0000500386.USD","HK0000252160.HKD"],"gpt_icon":0},{"id":"2591266246","title":"每日卖空追踪 | 映恩生物-B 12月15日卖空量成交1.07万股，卖空比例为1.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591266246","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591266246?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:30","pubTimestamp":1765787440,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间12月15日，跌5.58%，卖空量成交1.07万股，较上一交易日减少84.95%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215163622a44d434b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215163622a44d434b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000500386.USD","09606","HK0000252152.HKD","LU2543165471.USD","BK1161","HK0000252160.HKD"],"gpt_icon":0},{"id":"2591625626","title":"映恩生物-B12月15日遭主力抛售1191.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2591625626","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591625626?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:15","pubTimestamp":1765786543,"startTime":"0","endTime":"0","summary":"12月15日, 映恩生物-B股价跌5.58%，报收308.00元，成交金额2.6亿元，换手率0.94%，振幅7.97%，量比1.04。映恩生物-B今日主力资金净流出1191.8万元，连续5日净流出，上一交易日主力净流出208.1万元。该股近5个交易日下跌4.45%，主力资金累计净流出3806.6万元，其中3个交易日为股价上涨时净流出；近20日主力资金累计净流入852.5万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215161933a44d2ed5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215161933a44d2ed5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2543165471.USD","HK0000500386.USD","HK0000252160.HKD","09606","HK0000252152.HKD","BK1161"],"gpt_icon":0},{"id":"2591684936","title":"映恩生物-B(09606)建议采纳2025年股份计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2591684936","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591684936?lang=zh_cn&edition=full","pubTime":"2025-12-14 18:13","pubTimestamp":1765707202,"startTime":"0","endTime":"0","summary":"智通财经APP讯，映恩生物-B(09606)发布公告，于2025年12月13日，映恩生物(本公司，连同其附属公司统称本集团)的董事会议决建议采纳2025年股份计划，惟须经本公司股东批准方可作实。2025年股份计划旨在吸引及挽留对本集团长期发展及成功作出重要贡献的参与人士，表彰并奖励参与人士过去对本集团的贡献，为参与人士提供收购本公司专有权益的机会，并鼓励参与人士进一步为本公司作出贡献，致力提升本公司及其股份的价值，从而造福本公司及其全体股东。2025年股份计划将为本公司提供灵活的方式，以挽留、激励、奖励、酬劳、补偿参与人士及╱或为彼等提供福利。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381261.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000252160.HKD","LU2543165471.USD","HK0000252152.HKD","HK0000500386.USD","09606","BK1161"],"gpt_icon":0},{"id":"2590083765","title":"每日卖空追踪 | 映恩生物-B 12月12日卖空量成交1.51万股，卖空比例为2.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590083765","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590083765?lang=zh_cn&edition=full","pubTime":"2025-12-12 16:30","pubTimestamp":1765528238,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间12月12日，涨4.22%，卖空量成交1.51万股，较上一交易日减少50.97%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212165828a69b8663&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212165828a69b8663&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252160.HKD","HK0000500386.USD","LU2543165471.USD","BK1161","HK0000252152.HKD","09606"],"gpt_icon":0},{"id":"2590300277","title":"每日卖空追踪 | 映恩生物-B 12月10日卖空量成交2.73万股，卖空比例为5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590300277","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590300277?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:30","pubTimestamp":1765355440,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间12月10日，涨0.52%，卖空量成交2.73万股，较上一交易日减少52.02%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210163837a43fa12a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210163837a43fa12a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000500386.USD","09606","HK0000252152.HKD","LU2543165471.USD","HK0000252160.HKD","BK1161"],"gpt_icon":0},{"id":"2590395559","title":"每日卖空追踪 | 映恩生物-B 12月08日卖空量成交2.9万股，卖空比例为3.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590395559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590395559?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:30","pubTimestamp":1765182639,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间12月08日，跌3.75%，卖空量成交2.9万股，较上一交易日增加116.42%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208163627a72ab091&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208163627a72ab091&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252152.HKD","09606","LU2543165471.USD","BK1161","HK0000500386.USD","HK0000252160.HKD"],"gpt_icon":0},{"id":"2589804199","title":"智通港股通占比异动统计|12月8日","url":"https://stock-news.laohu8.com/highlight/detail?id=2589804199","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589804199?lang=zh_cn&edition=full","pubTime":"2025-12-08 08:36","pubTimestamp":1765154169,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，根据2025年12月5日披露数据，南方港美科技、狮腾控股、吉宏股份港股通持股占比增加值最大，分别增加1.35%、1.19%、0.75%；昊天国际建投、龙蟠科技、微盟集团港股通持股占比减少值最大，分别减少-0.93%、-0.83%、-0.59%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378570.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06869","06682","00694","01478","02600","01341","00638","09858","02013","02238","02465","03347","06166","01958","00568","02498","03678","02402","00347","09606","01138","02587","02550","02631","01385","02603","01282","02367","03319","00187","09863","06683","01233","02228","06865","01317","03759","02333","02648","06680","03958","01709","02582","02562","02202","01858","02208","09885"],"gpt_icon":1},{"id":"2589289697","title":"映恩生物-B12月05日主力净流出574.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2589289697","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589289697?lang=zh_cn&edition=full","pubTime":"2025-12-05 16:15","pubTimestamp":1764922530,"startTime":"0","endTime":"0","summary":"12月05日, 映恩生物-B股价跌1.98%，报收336.00元，成交金额2.2亿元，换手率0.75%，振幅4.14%，量比1.11。映恩生物-B今日主力资金净流出574.0万元，上一交易日主力净流入1105.8万元。该股近5个交易日下跌3.36%，主力资金累计净流入1476.3万元；近20日主力资金累计净流入7796.1万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205161730a7257d87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205161730a7257d87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2543165471.USD","BK1161","HK0000500386.USD","HK0000252152.HKD","HK0000252160.HKD","09606"],"gpt_icon":0},{"id":"1162267990","title":"映恩生物（09606）公布11月股份变动月报表，新增584,950股","url":"https://stock-news.laohu8.com/highlight/detail?id=1162267990","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162267990?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:51","pubTimestamp":1764838261,"startTime":"0","endTime":"0","summary":"映恩生物于2025年12月4日发布2025年11月股份变动月报表。报告期内，该公司法定股本维持在2亿股，面值0.0001美元，总额保持20,000美元不变。据月报显示，截至2025年11月30日，公司已发行普通股由上月底的88,294,264股增至88,879,214股，增加584,950股。本次新增发行主要来自首次公开发售前股权激励计划的行使，行使期权共计584,950股，所得资金约为港币3,555,743.85。月报同时披露，报告期内公司无股份回购及库存股变动。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"gpt_icon":0},{"id":"2588002989","title":"每日卖空追踪 | 映恩生物-B 12月04日卖空量成交1.31万股，卖空比例为2.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588002989","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588002989?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:30","pubTimestamp":1764837041,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间12月04日，涨5.28%，卖空量成交1.31万股，较上一交易日减少69.75%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163627a72359cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163627a72359cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU2543165471.USD","09606","HK0000500386.USD","HK0000252160.HKD","HK0000252152.HKD"],"gpt_icon":0},{"id":"2588002605","title":"映恩生物-B12月04日主力净流入1105.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2588002605","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588002605?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:15","pubTimestamp":1764836115,"startTime":"0","endTime":"0","summary":"12月04日, 映恩生物-B股价涨5.28%，报收342.80元，成交金额2.2亿元，换手率0.73%，振幅4.98%，量比0.98。映恩生物-B今日主力资金净流入1105.8万元，上一交易日主力净流出453.3万元。该股近5个交易日下跌1.61%，主力资金累计净流入1389.4万元；近20日主力资金累计净流入7796.5万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204161616952a7129&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204161616952a7129&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252160.HKD","HK0000500386.USD","LU2543165471.USD","HK0000252152.HKD","BK1161","09606"],"gpt_icon":0},{"id":"2588026170","title":"映恩生物创新药DB-1324获FDA IND批准，即将在美国启动临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2588026170","media":"制药在线","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588026170?lang=zh_cn&edition=full","pubTime":"2025-12-04 14:13","pubTimestamp":1764828826,"startTime":"0","endTime":"0","summary":"近日 ，映恩生物宣布，公司自主研发的新一代抗体偶联药物DB-1324新药临床试验申请已获得美国食品药品监督管理局的批准，即将在美国启动临床试验。基于对疾病生物学机制的深入研究和探索，映恩生物拥有丰富的临床ADC研发管线，并在超过20个国家开展多个全球多中心临床试验，入组超过2,700名患者。同时，映恩生物与全球制药公司和顶尖创新药企达成多项海外授权合作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204141351a4cbf115&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204141351a4cbf115&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09606","HK0000252152.HKD","BK1161","LU2543165471.USD","06978","HK0000500386.USD","HK0000252160.HKD"],"gpt_icon":0},{"id":"2588034954","title":"每日卖空追踪 | 映恩生物-B 12月02日卖空量成交3.31万股，卖空比例为7.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588034954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588034954?lang=zh_cn&edition=full","pubTime":"2025-12-02 16:30","pubTimestamp":1764664238,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间12月02日，跌0.53%，卖空量成交3.31万股，较上一交易日减少57.62%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202163555a71ebfd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202163555a71ebfd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09606","HK0000252152.HKD","HK0000252160.HKD","LU2543165471.USD","BK1161","HK0000500386.USD"],"gpt_icon":0},{"id":"2588709175","title":"智通港股通资金流向统计(T+2)|12月2日","url":"https://stock-news.laohu8.com/highlight/detail?id=2588709175","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588709175?lang=zh_cn&edition=full","pubTime":"2025-12-02 07:31","pubTimestamp":1764631861,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，11月27日,阿里巴巴-W、泡泡玛特、招商银行南向资金净流入金额位列市场前三，分别净流入9.11 亿、4.42 亿、3.66 亿小米集团-W、紫金矿业、腾讯控股南向资金净流出金额位列市场前三，分别净流出-6.88 亿、-4.22 亿、-2.61 亿在净流入比方面，四川成渝高速公路、中国海外宏洋集团、中国外运以68.85%、68.33%、65.67%位列市场前三。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376284.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00548","02888","09926","09988","HBBD.SI","00941","00598","HMTD.SI","06818","STAN.UK","06690","KSTmain","80883","02169","HXXD.SI","00777","81024","03347","02899","01860","00173","01361","03968","03877","00081","00107","06198","03143","03441","09606","HTCD.SI","02255","03033","02057","81810","02628","01186","00762","06969","02555","03323","09992"],"gpt_icon":1},{"id":"2586389271","title":"兴证国际：首予映恩生物-B(09606)“增持”评级 公司立足创新持续引领下一代ADC研发浪潮","url":"https://stock-news.laohu8.com/highlight/detail?id=2586389271","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586389271?lang=zh_cn&edition=full","pubTime":"2025-11-28 09:08","pubTimestamp":1764292136,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，兴证国际发布研报称，首次覆盖，给予映恩生物-B“增持”评级，映恩生物聚焦 ADC 赛道领域，借助与 BioNTech 等全球领先药企的合作，以中国速度推进全球多中心临床快速布局，在 ADC 领域占据有利的竞争身位。兴证国际主要观点如下：近期事件2025 年 10 月 23 日公司举办研发日，介绍公司 ADC 产品管线近期进展以及未来发展方向。2025 年 11 月 14 日公司自身免疫 ADC 产品管线 DB-2304用于系统性红斑狼疮临床全球 1/2a期研究的 2a 期部分完成首例患者给药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374883.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ADC","06058","09606"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dualitybiologics.com","stockEarnings":[{"period":"1week","weight":0.0727},{"period":"1month","weight":0.0569},{"period":"3month","weight":-0.1002},{"period":"6month","weight":0.342},{"period":"1year","weight":2.4926},{"period":"ytd","weight":2.4926}],"compareEarnings":[{"period":"1week","weight":0.0067},{"period":"1month","weight":0.0231},{"period":"3month","weight":-0.0137},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3084},{"period":"ytd","weight":0.2862}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"映恩生物是一家主要从事临床阶段生物制药的投资控股公司。该公司致力于为癌症和自身免疫性疾病等患者研发抗体偶联药物（ADC）创新药物。该公司的主要候选药物产品包括DB-1303/BNT323、DB-1311/BNT324、DB-1310、DB-1305/BNT325、DB-1419和DB-2304。该公司的产品主要用于靶向治疗子宫内膜癌（EC）、乳腺癌（BC）、小细胞肺癌（SCLC）、去势抵抗性前列腺癌（CRPC）、食管鳞状细胞癌（ESCC）及头颈部鳞状细胞癌（HNSCC）。该公司主要在国内和国外市场开展业务。","exchange":"SEHK","name":"映恩生物-B","nameEN":"DUALITYBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"映恩生物-B(09606)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供映恩生物-B(09606)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"映恩生物-B,09606,映恩生物-B股票,映恩生物-B股票老虎,映恩生物-B股票老虎国际,映恩生物-B行情,映恩生物-B股票行情,映恩生物-B股价,映恩生物-B股市,映恩生物-B股票价格,映恩生物-B股票交易,映恩生物-B股票购买,映恩生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"映恩生物-B(09606)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供映恩生物-B(09606)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}